GE Healthcare to invest $1 billion in cancer-related R&D

GE Healthcare announced Thursday that it plans to dedicate $1 billion of its total research and development budget over the next five years to expand its advanced cancer diagnostic and molecular imaging capabilities, as well as its technologies for the production of biopharmaceuticals and for cancer research. United Kingdom-based GE Healthcare has operations throughout southeastern Wisconsin, including its U.S. headquarters in Waukesha. A unit of Fairfield, Conn.-based General Electric Co. (NYSE:GE), GE Healthcare produces diagnostic medical imaging equipment at its Milwaukee-area plants. (MILWAUKEE BUSINESS JOURNAL, 9/16)